SAFC Injects $30 Million to Build Pharma Ingredients Capacity

Sigma Aldrich Fine Chemicals (SAFC; St Louis, MO) today announced plans to invest almost $30 million to build manufacturing capacity for high-potency active pharmaceutical ingredients (HPAPI) at the company's complex at Madison, WI. The investment follows recent completion of a $15-million HPAPI capacity expansion at the site. The latest expansion program will increase capacity at the site by “substantially more than 20%,” Michael Harris, v.p./sales and production for SAFC in Europe told journalists at a briefing held by the company in Lyon, France...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers